Clotrimazole And Betamethasone Dipropionate
Pricing Report NDC 66993-898-45

Latest NADAC: $0.25300 per GM · Effective Nov 21, 2018 · Est. package price $11.39 (45 GM)

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Clotrimazole And Betamethasone Dipropionate (NDC 66993-898-45) is $0.25300 per GM. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Nov 21, 2018.

As a provided by Prasco Laboratories, this medication is distributed in a 1 TUBE in 1 BOX / 45 g in 1 TUBE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.25300
Per GM

Effective Date
Nov 21, 2018
Billable Units
45 GM
Estimated Package Price
$11.39
Data Status
As of Nov 28, 2018
C/I - Chain or Independent Pharmacy
Package NDC
Description
1 TUBE in 1 BOX / 45 g in 1 TUBE
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The NADAC was calculated based on package size.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Nov 2013, the NADAC wholesale price for (NDC ) has moved within a range of $0.24835 to $1.13554 per GM. Over this 5 years and 6 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.2906 - $1.1355
Market Volatility
290.74% Variance
Latest Trend
6.87%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Jun 19, 2019 $0.34455 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
May 22, 2019 $0.32240 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Apr 17, 2019 $0.29427 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Mar 20, 2019 $0.29682 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Feb 20, 2019 $0.30782 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jan 23, 2019 $0.29941 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Dec 19, 2018 $0.30033 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Nov 21, 2018 $0.29061 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Nov 21, 2018 $0.25300 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Oct 17, 2018 $0.32956 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Oct 17, 2018 $0.24835 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Sep 19, 2018 $0.38584 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 5: The NADAC was calculated based on package size.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026